An agent harness for drug design separates failed computations from genuine negative results
- ETALON wraps a general-purpose coding agent in an environment for computer-aided drug design, built from three usable-alone systems covering evidence, preparation, screening and docking, and generation with physical modeling.
- Operations are checked before dispatch, and outputs record completion, verification and admission separately, so a failed run is not logged as a negative result.
- A persistent research graph carries evidence across sessions.
- The abstract reports no benchmark results.
💡 Points Based on the abstract
With no benchmark reported, ETALON can only be judged on its bookkeeping. Separating completion, verification and admission is the useful idea, because a crashed docking job quietly logged as inactive is how good chemotypes get dropped. Ask for an ablation against the bare coding agent, and audit the logs on a pilot project.
ETALON: Verified Execution and Persistent Research Memory for Agentic Computer-Aided Drug Design ↗